Aurora Cannabis shares surged as federal rescheduling discussions renewed investor optimism. The rally highlights how regulatory expectations are currently the biggest driver in cannabis capital markets.

A proposed 2026 ballot question in Newton could reverse adult use cannabis legalization at the local level, shutting down retail and personal cultivation. The situation highlights how local politics can directly impact licenses, investments, and market access.

The Trump administration declined to file a government brief in a major Supreme Court cannabis case, signaling reduced federal engagement in shaping cannabis policy. The move highlights ongoing uncertainty at the federal level as courts, states, and agencies continue defining the future of cannabis regulation.

Rep. Nancy Mace has introduced draft legislation aimed at reversing the new federal ban on intoxicating hemp products. The proposal could offer major relief to the $28 billion hemp-THC sector, which was blindsided by the ban buried in the government-funding deal.

Thirty-seven state attorneys general have urged Congress to ban hemp-derived THC products, citing health and enforcement concerns. Their unified call for federal action could reshape the future of hemp regulation — and impact every operator in the space.

New York regulators have charged Omnium Canna with allegedly allowing unlicensed operators to manufacture and package cannabis under its license. The “rent-a-license” case exposes serious weaknesses in the state’s track-and-trace system and highlights why compliance and risk management are critical for cannabis operators.

Massachusetts cannabis advocates are fighting to keep the state’s $1.6 billion market alive as a repeal campaign gains momentum for the 2026 ballot. The outcome could redefine legalization not only in Massachusetts but across the country — and serve as a wake-up call for cannabis operators to prepare for regulatory risk.